InvestLog
CABA logo

CABA

Cabaletta Bio, Inc.NASDAQHealthcare
$2.96+1.69%ClosedMarket Cap: $284.9M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-24Morgan Stanley—Overweight—
2026-03-24Guggenheim—Buy—
2025-10-31Cantor Fitzgerald—Overweight—
2025-10-10HC Wainwright & Co.—Buy—
2025-09-05Cantor Fitzgerald—Overweight—
2025-08-14Citigroup—Buy—
2025-08-08Wells Fargo—Equal Weight—
2025-08-08Guggenheim—Buy—
2025-06-11HC Wainwright & Co.—Buy—
2025-05-16Guggenheim—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.55$712.6K4
Sun Dec 31$-1.52$81.3M7
Mon Dec 31$-0.76$379.7M2
Tue Dec 31$0.98$810.9M5